Using a combination of TRPC-deficient mouse models and pharmacological tools, we unveiled that functional loss of TRPC5 in catecholaminergic cells leads to a defective counter-regulation to insulin-evoked hypoglycemia due to lack of increase in plasma adrenaline, thereby disabling the re-establishment of euglycemia. The gene discussed is INS; the disease is Hypoglycemia.